Back to home


Hugging Patients During a Pandemic

Beth Sandy, MSN, CRNP Beth Sandy, MSN, CRNP

Read more

COVID-19 and Caring for Cancer Patients

Avani Yenamandra, PharmD Avani Yenamandra, PharmD

Coronaviruses are a large family of viruses that are common in people and animals. SARS-CoV-2, a novel coronavirus, causes a respiratory disease called coronavirus disease 2019, abbreviated COVID-19.1,2 Immunocompromised patients, especially those who have cancer and undergoing treatment, pose to ...

Read more

Mobocertinib, a First-In-Class Oral Therapy for EGFR Exon 20 Insertion-Positive NSCLC

Christian Watts Pharm.D., MSHI Candidate, Larry Buie Pharm.D., BCOP, FCCP, FASHP, Beth Sandy, MSN, CRNP Christian Watts Pharm.D., MSHI Candidate, Larry Buie Pharm.D., BCOP, FCCP, FASHP, Beth Sandy, MSN, CRNP


Read more

Cancer-related Fatigue After Receiving Chemotherapy Treatment: Should Additional Pharmacologic Recommendations Be Considered?

Amari Marshall & Abigail Shockley, PharmD Amari Marshall & Abigail Shockley, PharmD

According to the American Cancer Society, between 80 and 100% of patients with cancer report fatigue.1 Fatigue can be present while receiving active anticancer treatment and can persist for as long as 12 months after treatment cessation. In 2000, the National Comprehensive Cancer Network (NCCN) ...

Read more

Fam-Trastuzumab Deruxtecan (Enhertu) for HER 2 Amplified Gastric Adenocarcinoma

Christina Bartholomew Christina Bartholomew

Although treatment strategies for patients with metastatic gastric cancer who have failed prior lines of therapy remain limited, novel agents such as trastuzumab deruxtecan (Enhertu), provide further options for patients with HER2-positive disease.

Read more

Daratumumab Addition to Treatment of Immunoglobulin Light-Chain Amyloidosis (ANDROMEDA)

Marissa Duco, PharmD Marissa Duco, PharmD

Immunoglobulin light-chain (AL) amyloidosis is a malignancy of the plasma cells which express CD38 and produce misfolded proteins that lead to organ damage, primarily of the heart and kidneys. The standard treatment of AL amyloidosis is bortezomib, cyclophosphamide, and dexamethasone which is ...

Read more

Antibody Response to COVID-19 mRNA Vaccines in Patients with Hematologic Malignancies

Alice Wang, PharmD Alice Wang, PharmD

On August 13, 2021, the Food and Drug Administration (FDA) expanded the Emergency Use Authorization for the Pfizer and Moderna COVID-19 vaccines to recommend a third dose for certain immunocompromised patients.1 This recommendation was based on data suggesting that these patients experienced ...

Read more